SKAN Group AG (LTS:0SKN) Capex-to-Operating-Income : 0.99 (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is SKAN Group AG Capex-to-Operating-Income?

Capex-to-Operating-Income measures a company's investments in physical assets such as property, industrial buildings or equipment to its operating income.

SKAN Group AG's Capital Expenditure for the six months ended in Dec. 2023 was CHF-25.12 Mil. Its Operating Income for the six months ended in Dec. 2023 was CHF25.35 Mil.

Hence, SKAN Group AG's Capex-to-Operating-Income for the six months ended in Dec. 2023 was 0.99.

SKAN Group AG Capex-to-Operating-Income Historical Data

The historical data trend for SKAN Group AG's Capex-to-Operating-Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SKAN Group AG Capex-to-Operating-Income Chart

SKAN Group AG Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Capex-to-Operating-Income

1.36

1.85

0.98

0.94

SKAN Group AG Semi-Annual Data
	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Capex-to-Operating-Income	Get a 7-Day Free Trial			1.85	2.67	0.56	0.82	0.99

Competitive Comparison of SKAN Group AG's Capex-to-Operating-Income

For the Medical Instruments & Supplies subindustry, SKAN Group AG's Capex-to-Operating-Income, along with its competitors' market caps and Capex-to-Operating-Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

SKAN Group AG's Capex-to-Operating-Income Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, SKAN Group AG's Capex-to-Operating-Income distribution charts can be found below:

* The bar in red indicates where SKAN Group AG's Capex-to-Operating-Income falls into.

SKAN Group AG Capex-to-Operating-Income Calculation

SKAN Group AG's Capex-to-Operating-Income for the fiscal year that ended in Dec. 2023 is calculated as

Capex-to-Operating-Income	=	- Capital Expenditure	/	Operating Income
	=	- (-35.298)	/	37.749
	=	0.94

SKAN Group AG's Capex-to-Operating-Income for the quarter that ended in Dec. 2023 is calculated as

Capex-to-Operating-Income	=	- Capital Expenditure	/	Operating Income
	=	- (-25.122)	/	25.348
	=	0.99

SKAN Group AG (LTS:0SKN) Capex-to-Operating-Income Explanation

Capex-to-Operating-Income assesses how much emphasis a company is placing upon investing in capital-intensive projects. The ratio is generally a good gauge to quantify how much focus on growth a company has. Typically, smaller companies that are still growing and expanding will have a higher Capex to Operating Income Ratio, since such businesses are likely investing more in physical assets. Lower ratios could indicate that a company has reached maturity and it is no longer pursuing aggressive growth.

SKAN Group AG Capex-to-Operating-Income Related Terms

Thank you for viewing the detailed overview of SKAN Group AG's Capex-to-Operating-Income provided by GuruFocus.com. Please click on the following links to see related term pages.

SKAN Group AG (LTS:0SKN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » SKAN Group AG (LTS:0SKN) » Definitions » Capex-to-Operating-Income

Comparable Companies

Traded in Other Exchanges

SKANz:UK SKAN:Switzerland

Address

Kreuzstrasse 5, Allschwil, CHE, 4123

Website

https://www.skan.com

SKAN Group AG is a global market and technological company for isolators, cleanroom devices, and decontamination processes for the aseptic production of biopharmaceutical substances. Its core competency is the design and development of process isolators for the aseptic filling of biopharmaceutical products. The company offer its customers process support, services, and consumables. Its products include biological indicators, isolators, Laboratory/cleanroom equipment, laminar flow, safety workbench, and transfer system.

SKAN Group AG (LTS:0SKN) Headlines

No Headlines